Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-01-06
DOI
https://doi.org/10.3389/fmed.2025.1721311
Citations
1
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
30.73

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials

Bingyan Gu, Zhexuan Yu, Weifeng Jin, Wei Jin et al.
1 citations
Frontiers in Medicine
Diabetes Treatment and Management
30.73
article

Novel antidiabetic agents and the risk of respiratory diseases: a systematic review and meta-analysis of 27 randomized controlled trials

Bingyan Gu, Zhexuan Yu, Weifeng Jin, Wei Jin, Haitong Wan, Junyao Zhang
article en
1 citations

Abstract

No abstract available for this paper.
Frontiers in MedicineVol. 12
Zhejiang Chinese Medical University (CN)
Zhejiang Chinese Medical University, Natural Science Foundation of Zhejiang Province
Good health and well-being
Openalex Percentile: Top 3%
Diabetes Treatment and Management
30.73
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.